81379 HLA Class I typing, high resolution (ie, alleles or allele groups); complete (ie, HLA-A, -B, and -C)

Name of the Procedure:

HLA Class I Typing, High Resolution (HLA-A, -B, and -C Typing)

Summary

HLA Class I typing is a genetic test to identify specific alleles and allele groups of Human Leukocyte Antigens (HLA) -A, -B, and -C. These antigens are proteins found on the surface of cells that play a crucial role in immune system functioning, especially in organ transplantation and disease susceptibility.

Purpose

HLA Class I typing is primarily used to:

• Determine compatibility for organ and bone marrow transplantation.
• Assess disease susceptibility related to certain HLA types.
• Guide treatment plans for individuals with certain autoimmune conditions.

Indications

• Patients awaiting organ or bone marrow transplantation.
• Individuals with suspected autoimmune disorders.
• People with a family history of HLA-associated diseases.
• Patients participating in certain clinical trials.

Preparation

• No special preparation is usually needed.
• Patients may be advised to inform their physician about any medications they are taking.

Procedure Description

1. Sample Collection: A blood sample is collected from the patient, often using a sterile needle. Alternatively, a buccal cheek swab may be used.
2. DNA Extraction and Amplification: DNA is extracted from the collected sample and then amplified using Polymerase Chain Reaction (PCR).
3. Sequencing: The amplified DNA is sequenced to a high resolution to identify specific HLA alleles.
4. Analysis: Specialized software and bioinformatic tools are used to interpret the sequencing data and generate an HLA typing report.

Duration

The procedure typically takes a few hours for sample collection and several days to a couple of weeks for results to be analyzed and reported.

Setting

The sample collection is usually performed in a clinical setting such as a hospital, outpatient clinic, or laboratory.

Personnel

• Phlebotomist or clinician for blood draw.
• Laboratory technicians and molecular biologists for DNA extraction, amplification, sequencing, and analysis.
• Medical geneticists or pathologists to interpret results.

Risks and Complications

• Minimal risks associated with blood draw, such as slight bruising or infection at the puncture site.
• Rarely, complications from the collection process if a buccal swab is used, such as minor discomfort.

Benefits

• Accurate determination of HLA compatibility can significantly reduce the risk of organ transplant rejection.
• Helps in diagnosing and managing certain autoimmune diseases.
• Aids in personalized medical treatment planning.

Recovery

• No specific recovery period is needed for the procedure as it is minimally invasive.
• Patients can return to their normal activities immediately after sample collection.

Alternatives

• Low-resolution HLA typing, which provides less specific information but may be faster and more cost-effective.
• Serological HLA typing, an older method using antibodies to identify HLA molecules, though it is less precise than DNA-based methods.

Patient Experience

• The patient might feel a brief prick during the blood draw or slight discomfort during a buccal swab.
• Post-procedure, they can expect minimal to no discomfort and can resume usual activities right away.
• Any discomfort can be managed with simple over-the-counter pain relief if necessary.